dihexa clinical trials or human studies or safety Dihexa dihexa human studies clinical trials
Description
Lyashchenko, K
KPV is studied for anti-inflammatory activity, specifically NF-kB inhibition and preferential uptake in inflamed intestinal tissue via the PepT1 transporter
Practical Regimens for Achieving 40 Grams Daily Resistant Starch Healthcare providers frequently encounter patients who could benefit from higher doses of resistant starch, particularly those with severe metabolic dysfunction or inflammatory conditions
Parameters compared included age at symptom onset, gender, clinical symptoms, risk factors, autoantibodies, and cerebrospinal fluid findings
